Linda A. Johnson

Patients in poor countries struggle despite low prices


TRENTON, N.J. — Cancer drugs predictably cost much more in the U.S. than in poor countries and even other wealthy nations, but... Read more

Pfizer buying skin drug maker Anacor for $5.2 billion


TRENTON, N.J. — Pfizer is fortifying its key immunology and inflammation drug business, snapping up a small maker of skin... Read more

Valeant files overdue financial report, ending debt default

Valeant Pharmaceuticals resolved its default on some of its $30 billion in debt by finally filing its long-overdue U.S. financial report... Read more

Jury orders Gilead to pay $200 million to Merck

The federal jury in a patent trial has ordered drugmaker Gilead Sciences to pay Merck $200 million in damages... Read more

Drugmaker Valeant reveals SEC inquiry


Valeant Pharmaceuticals is entangled in an SEC investigation that compounds the drugmaker’s headaches as it grapples with... Read more